1567 
Elekta, world leader in advanced radiation therapy, comprehensive cancer management and noninvasive treatment of brain disorders, has announced the acquisition of 3D Line Medical Systems. Through this acquisition, Elekta adds a highly qualified R&D group specialised in stereotactic radiosurgery and dynamic IMRT treatments, as well as a product portfolio of advanced equipment and treatment planning software systems for performing radiation therapy with extreme precision and optimised dose distribution.
Subject to customary closing conditions, Elekta will pay €10 million in cash for assets in 3D Line Medical Systems (3D Line) related to radiation therapy, and up to a maximum of €8 million, based on future performance over the coming three years. Elekta expects to consolidate 3D Line into its accounts from 1 May 2007.
